If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

or COPD, was the sixth leading cause of death in the U.S. in 2020. Every five minutes, an American is diagnosed with the life-changing disease. Until recently, the primary treatment options were ...

Ohtuvayre (ensifentrine) for COPD: Approved June 26, the inhaled medication is the first new type of maintenance COPD drug in over a decade ... First approved in 2020, the oral medication can ...

Here, Tan and other experts in the field describe how this new understanding of inflammation is informing treatment. And it's ...